RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
The post RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace